Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PVA Plus
- Development stage
- Unknown
- Lead developer
- Akorn Holdings
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
PVA Plus is an over-the-counter (OTC) ophthalmic lubricant used for the temporary relief of burning and irritation caused by dry eyes or exposure to environmental factors such as wind and sun. It is a combination formulation typically containing polyvinyl alcohol (1.4%) and povidone (0.6%). Polyvinyl alcohol is a water-soluble synthetic polymer that increases the viscosity of the solution, thereby prolonging the contact time with the ocular surface and stabilizing the tear film. Povidone, also known as polyvinylpyrrolidone, serves as a demulcent that provides a soothing effect and reduces friction during blinking. Together, these ingredients act as a tear substitute to maintain ocular hydration and protect the corneal epithelium from mechanical irritation and moisture loss.
- Brand names
- PVA Plus
- Other names
- Polyvinyl alcohol/povidone ophthalmicPVA/Povidone
Beyond the preview
Go deeper on PVA Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PVA Plus.